Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis (Q27653976)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis	scientific article

Statements

instance of

scholarly article

0 references

title

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis (English)

0 references

main subject

Mycobacterium tuberculosis

0 references

author

Jean-Emmanuel Hugonnet

object named as

Jean-Emmanuel Hugonnet

series ordinal

1

0 references

Clifton E Barry

object named as

Clifton E Barry

series ordinal

4

0 references

John S Blanchard

series ordinal

5

object named as

John S Blanchard

0 references

author name string

Lee W Tremblay

series ordinal

2

0 references

Helena I Boshoff

series ordinal

3

0 references

language of work or name

English

0 references

publication date

27 February 2009

0 references

published in

Science

0 references

volume

323

0 references

issue

5918

0 references

page(s)

1215-8

0 references

cites work

Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

Activity of amoxicillin/clavulanate in patients with tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

20 March 2017

Tuberculosis - metabolism and respiration in the absence of growth

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

29 September 2017

Persistent and dormant tubercle bacilli and latent tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

29 September 2017

M. tuberculosis persistence, latency, and drug tolerance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

29 September 2017

How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

29 September 2017

Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679150

retrieved

2 June 2018

Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1126%2FSCIENCE.1167498

retrieved

21 January 2018

The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1126%2FSCIENCE.1167498

retrieved

21 January 2018

Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1126%2FSCIENCE.1167498

retrieved

21 January 2018

Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19251630

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1126/SCIENCE.1167498

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1349334

OpenCitations bibliographic resource ID

1349334

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1349334

PMC publication ID

2679150

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1349334

PubMed publication ID

19251630

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1349334

ResearchGate publication ID

24146168

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27653976&oldid=2139648490"